Skip to content
thestock.space

On 8 Sep 2026, Ganga Pharmaceuticals was priced at ₹12.50, or 73.5× trailing earnings, and the shares are 14% below their 52-week high. It earns ROCE of 3.0% and ROE of 1.3%, and sales and net profit grew 3.0% and 37% a year over 3 years. Debt is 0.13× equity. It is a small-cap company with a market cap of ₹7.39 Cr; the shares fell 14% over the past year.

As of 8 Sep 2026Prices are delayed about 15 minutes.How we calculate this

past year
Open
₹12.00
Day high
₹12.50
Day low
₹12.00
Prev. close
₹12.50
Volume
16K

Health check

1 good · 4 to check
  • ReturnsWeak

    −14.4% over the past year.

  • Price tagNo peers

    P/E 73.5, with no peers to compare.

  • GrowthStrong

    Sales +3.0%, profit +37.2% a year over 3 years.

  • ProfitabilityWeak

    ROCE 3.0%.

  • Balance sheetStretched

    Debt 0.13× equity, interest covered 0.3×.

  • Red flags2 to check

    Return on equity is low at 1.3%.

Computed from reported figures. Educational, not a recommendation.

Drug Manufacturers - Specialty & Generic

Screen the industry

Small cap

₹7.39 Cr

Defensive

Beta 0.38 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months: sales ₹3 Cr · profit ₹0 Cr
Market cap
₹7.39 Cr
Small cap
P/E
73.5
Price to book
0.89
Book value ₹14.06
Dividend yield
0.00%
ROE
1.3%
Return on equity
ROCE
3.0%
Return on capital employed
Debt to equity
0.13
Debt ₹1.09 Cr
EPS (TTM)
₹0.17
OPM (TTM)
2.1%
Net margin 3.6%
Sales growth
+10.2%
Latest quarter vs a year ago
Profit growth
+104.8%
Latest quarter vs a year ago
Price to sales
2.61
EV/EBITDA 215.4

Strengths and risks

Strengths

  • Quarterly profit up 104.8% on a year ago.

Risks to check

  • Return on equity is low at 1.3%.
  • Interest coverage of only 0.3×.

Derived automatically from reported figures. Not a recommendation.

About Ganga Pharmaceuticals

Ganga Pharmaceuticals Limited engages in the manufacturing, marketing, and distribution of ayurvedic medicines in India. The company was incorporated in 1989 and is based in Mumbai, India.

Headquarters
Mumbai
Employees
17
Sector
Healthcare
ISIN
INE615T01017
Website
ayurvedganga.com

Price range

52 weeks

₹9.35₹14.60

Today

₹12.00₹12.50
Avg volume (3M)
258
1-year return
minus 14.4%
From 52-week high
minus 14.4%

Peers

We couldn’t find listed peers for this company.

Quarterly results

This company doesn’t report these figures in a format we can read yet.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+3.0%
Profit CAGR 3Y
+37.2%
ROE
1.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2.62.72.62.8
–+5.8%minus 3.6%+7.2%
2.62.72.82.8
00.1−0.10
0.2%2.1%−4.4%1.4%
0.30.20.20.3
0.20.20.20.1
0.1000.1
––0.2–
0.10.10.10.1
26.0%26.3%16.6%21.5%
000.10.1
–+18.6%+69.5%+28.5%
0.100.070.12–

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4.14.84.85.9
1.42.22.32.4
1.81.41.41.1
0.70.20.40.2
88.699.6
0.60.60.70.6
0.10.8––
000.30.1
7.27.288.9
88.699.6

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−0−1.3−0.6−1.3
0.50.11.20.2
−0.41.1−0.30.8
000.3−0.2
−0−0−0.1−0
−0.1−1.3−0.7−1.3

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you